Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cspdcl
Shijiazhuang, Hebei, Chinacspdcl.co.in ↗
- Ownership
- Private
- Employees
- ~15000
- Development stage
- Other
01
Overview
CSPC Pharmaceutical Group is one of China's largest pharmaceutical companies. It develops, manufactures, and sells APIs and finished formulations across antibiotics, cardiovascular drugs, oncology therapies, CNS agents and more. The company has over 15,000 employees in multiple subsidiaries. Its portfolio includes both innovative biologics/biosimilars as well as small molecules. Recent deals include major outlicensing to multinationals such as AstraZeneca for preclinical cardiovascular assets. The group is active in global partnerships and licensing.
- Therapeutic areas
- OncologyDermatologyCardiovascularNeurology
- Modalities
- Small moleculeMonoclonal antibodyAntibody-drug conjugateBiosimilarmRNA-based drugs
- Industry
- Biotech
02
Partnerships
AstraZeneca ($100 million upfront + up to $1.92 billion milestones for Lp(a) asset)Other ongoing licensing deals with global pharma partners
Beyond the preview
Go deeper on Cspdcl.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Cspdcl.